"Important": Delhi High Court on petitions seeking RTI details about development of Covaxin

The petitioner was denied information by the Health Ministry on the purchase orders and advance purchase orders for Covaxin vaccines.
Covaxin, Bharat Biotech
Covaxin, Bharat Biotech

The Delhi High Court on Monday said that it will hear in January the petitions challenging denial of information under Right to Information (RTI) Act about investments and costs that went into developing Covaxin, India's indigenous vaccine against COVID-19. 

Want to read the full story?

We’re glad you’re enjoying this story. Subscribe to any of our plans to continue reading the story.

Already have an account? Sign In
Bar and Bench - Indian Legal news